Research graph
References from Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience. Local targets link to admitted publications; unresolved targets remain external evidence.
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
10.1200/jco.2004.12.149 · 2004 · External reference
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group
10.1056/nejm199908123410703 · 1999 · External reference
Evaluation of first-line radiosurgery vs. whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study
10.1001/jamaoncol.2020.1271 · 2020 · External reference
State-of-the-art considerations in small cell lung cancer brain metastases
10.18632/oncotarget.19333 · 2017 · External reference
Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial
10.1001/jama.295.21.2483 · 2006 · External reference
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study
10.1200/jco.2010.30.1655 · 2011 · External reference
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
10.1016/s1470-2045(09)70263-3 · 2009 · External reference
Radiosurgery alone is associated with favorable outcomes for brain metastases from small cell lung cancer
10.1016/j.lungcan.2018.03.027 · 2018 · External reference
Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients
10.1186/s12885-015-1103-6 · 2015 · External reference
Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma
10.3171/jns.2002.97.supplement · 2002 · External reference
Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis
10.1016/s1470-2045(22)00271-6 · 2022 · External reference
Prophylactic cranial irradiation versus observation in patients with extensive disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial
10.1016/s1470-2045(17)30230-9 · 2017 · External reference
10.1056/nejmoa071780
10.1056/nejmoa071780 · 2007 · External reference
Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again?
10.21037/jtd.2017.10.10 · 2017 · External reference
What is the current role of prophylactic cranial irradiation in the treatment algorithm for small cell lung cancer?
10.5603/rpor.97432 · 2023 · External reference
PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients
10.1016/j.lungcan.2024.107993 · 2024 · External reference
Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell lung cancer: a randomized phase III NVALT11/DLCRG-02 study
10.1200/jco.2017.77.5817 · 2018 · External reference
Unresolved reference
2025 · External reference
Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN
10.1016/j.esmoop.2022.100408 · 2022 · External reference
First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer
10.1056/nejmoa1809064 · 2018 · External reference
Unresolved reference
External reference
Predicting survival with brain metastases in the stereotactic radiosurgery era: are existing prognostic scores still relevant? Or can we do better?
10.1016/j.clon.2024.01.037 · 2024 · External reference
Stereotactic radiosurgery in patients with small cell lung cancer and 1-10 brain metastases: a multi-institutional, phase II, prospective clinical trial
10.1200/jco.2024.42.16_suppl.2020 · 2024 · External reference
Survival after stereotactic radiosurgery in the era of targeted therapy: number of metastases no longer matters
10.3390/curroncol31060228 · 2024 · External reference
Response of treatment-naive brain metastases to stereotactic radiosurgery
10.1038/s41467-024-47998-8 · 2024 · External reference
Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer
10.3857/roj.2015.33.3.207 · 2015 · External reference
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy—a phase III study of the European organization for the research and treatment of cancer lung cancer cooperative group
10.1200/jco.2000.18.19.3400 · 2000 · External reference
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
10.1200/jco.2011.38.0527 · 2012 · External reference
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)
10.1093/jnci/djad073 · 2023 · External reference
Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)
10.1007/s11060-016-2216-8 · 2016 · External reference
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the phase III IMpower133 study and the phase III IMbrella A extension study
10.1016/j.lungcan.2024.107924 · 2024 · External reference
